Table 2 Definition criteria and antibiotic panel for Pseudomonas aeruginosa
From: The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods
Antimicrobial category | ECDC-MDR | KRINKO-3MRGN | KRINKO-4MRGN | UHZ-MDR |
|---|---|---|---|---|
Antipseudomonal penicillins | Piperacillin/ tazobactam or ticarcillin/ clavulanic acid | Piperacillin a) | Piperacillin a) | Piperacillin/ tazobactam |
Extended spectrum cephalosporins | Ceftazidime or cefepime | Ceftazidime and cefepime | Ceftazidime and cefepime | Ceftazidime and cefepime |
Carbapenems | Imipenem or meropenem or doripenem | Imipenem and meropenem | Imipenem and meropenem | Imipenem or meropenem |
Quinolones | Ciprofloxacin or levofloxacin | Ciprofloxacin | Ciprofloxacin | Ciprofloxacin and levofloxacin |
Aminoglycosides | Amikacin or gentamicin or tobramycin or netilmicin | ≥2 of: Amikacin, gentamicin, tobramycin | ||
Monobactams | Aztreonam | |||
Phosphonic acids | Fosfomycin | |||
Polymyxins | Colistin or polymyxin B | |||
Definition of MDR | Resistant to ≥3 categories | Resistant to 3 out of 4 categories | Resistant to all 4 categories | Resistant to 3 out of 5 categories |